NCT01360164View on ClinicalTrials.gov

Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Hereditary Ataxia

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2013

Conditions
Hereditary Ataxia
Interventions
BIOLOGICAL

human umbilical cord mesenchymal stem cells

Participants will be given hUC-MSCs transplantation.

Trial Locations (1)

Unknown

RECRUITING

Nanjing University Medical College Affiliated Drum Tower Hospital, Nanjing

Sponsors
All Listed Sponsors
collaborator

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

OTHER

collaborator

Nanjing Medical University

OTHER

collaborator

Nanjing University Medical College Affiliated Wuxi Second Hospital

UNKNOWN

collaborator

Xuzhou Medical University

OTHER

collaborator

The Second Hospital of Nanjing Medical University

OTHER

lead

Shenzhen Beike Bio-Technology Co., Ltd.

INDUSTRY

NCT01360164 - Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Hereditary Ataxia | Biotech Hunter | Biotech Hunter